...
首页> 外文期刊>PLoS Medicine >South Asia as a Reservoir for the Global Spread of Ciprofloxacin-Resistant Shigella sonnei: A Cross-Sectional Study
【24h】

South Asia as a Reservoir for the Global Spread of Ciprofloxacin-Resistant Shigella sonnei: A Cross-Sectional Study

机译:南亚作为耐环丙沙星的志贺氏志贺氏菌全球扩散的储库:一项跨部门研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Antimicrobial resistance is a major issue in the Shigellae, particularly as a specific multidrug-resistant (MDR) lineage of Shigella sonnei (lineage III) is becoming globally dominant. Ciprofloxacin is a recommended treatment for Shigella infections. However, ciprofloxacin-resistant S. sonnei are being increasingly isolated in Asia and sporadically reported on other continents. We hypothesized that Asia is a primary hub for the recent international spread of ciprofloxacin-resistant S. sonnei. Methods and Findings We performed whole-genome sequencing on a collection of 60 contemporaneous ciprofloxacin-resistant S. sonnei isolated in four countries within Asia (Vietnam, n = 11; Bhutan, n = 12; Thailand, n = 1; Cambodia, n = 1) and two outside of Asia (Australia, n = 19; Ireland, n = 16). We reconstructed the recent evolutionary history of these organisms and combined these data with their geographical location of isolation. Placing these sequences into a global phylogeny, we found that all ciprofloxacin-resistant S. sonnei formed a single clade within a Central Asian expansion of lineage III. Furthermore, our data show that resistance to ciprofloxacin within S. sonnei may be globally attributed to a single clonal emergence event, encompassing sequential gyrA-S83L, parC-S80I, and gyrA-D87G mutations. Geographical data predict that South Asia is the likely primary source of these organisms, which are being regularly exported across Asia and intercontinentally into Australia, the United States and Europe. Our analysis was limited by the number of S. sonnei sequences available from diverse geographical areas and time periods, and we cannot discount the potential existence of other unsampled reservoir populations of antimicrobial-resistant S. sonnei. Conclusions This study suggests that a single clone, which is widespread in South Asia, is likely driving the current intercontinental surge of ciprofloxacin-resistant S. sonnei and is capable of establishing endemic transmission in new locations. Despite being limited in geographical scope, our work has major implications for understanding the international transfer of antimicrobial-resistant pathogens, with S. sonnei acting as a tractable model for studying how antimicrobial-resistant Gram-negative bacteria spread globally.
机译:背景技术抗菌素耐药性是志贺氏菌中的一个主要问题,特别是随着志贺氏志贺氏菌的特定多药耐药性(MDR)谱系(谱系III)在全球范围内占主导地位。推荐使用环丙沙星治疗志贺氏菌感染。但是,耐环丙沙星的S. sonnei在亚洲越来越孤立,在其他大洲也有零星报道。我们假设亚洲是最近对环丙沙星耐药的沙门氏菌国际传播的主要中心。方法和发现我们对在亚洲四个国家(越南,n = 11;不丹,n = 12;泰国,n = 1;柬埔寨,n = 1)中分离的60个同时期耐环丙沙星的葡萄球菌进行了全基因组测序。 1)和亚洲以外的两个国家(澳大利亚,n = 19;爱尔兰,n = 16)。我们重建了这些生物的最新进化史,并将这些数据与其隔离地理位置相结合。将这些序列放入一个全局系统发育树中,我们发现所有耐环丙沙星的S. sonnei都在中亚沿革III扩展中形成了一个进化枝。此外,我们的数据显示,S。sonnei中对环丙沙星的抗药性可能总体上归因于单个克隆出现事件,包括连续的gyrA-S83L,parC-S80I和gyrA-D87G突变。地理数据预测,南亚可能是这些生物的主要来源,它们被定期出口到整个亚洲,并陆续出口到澳大利亚,美国和欧洲。我们的分析受到可从不同地理区域和时间段获得的S. sonnei序列数量的限制,并且我们不能轻视其他未采样的抗微生物S. sonnei的潜在种群。结论这项研究表明,在南亚广泛分布的单个克隆可能会推动目前对环丙沙星耐药的S. sonnei洲际激增,并能够在新的地方建立地方性传播途径。尽管地域范围有限,但我们的工作对于理解抗药性病原体的国际转移具有重大意义,其中S. sonnei可作为研究抗药性革兰氏阴性菌如何在全球范围内传播的易处理模型。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号